From Name:
From Email:
To Name:
To Email:

Optional Message:

Big Pharma replaces innovation with acquisition

from By Mike Wokasch

Big Pharma, including Big Biotech, has executed about 130 mergers or acquisitions in each of the past couple of years. The overwhelming majority of deals designed to fill depleted Big Pharma pipelines with more novel and innovative technologies in later stages than their own R&D had been able to produce. If Big Pharma is relying on others to do drug discovery, how deep does the discovery pipeline have to go to be indefinitely sustainable? more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063